The ability of A2-derived HBV vaccines to protect against non-A2 HBV genotypes has recently been brought into question following the publication of a study of 3.7 million blood donors in the USA. [25] ...
Please provide your email address to receive an email when new articles are posted on . Fast track designation has been granted to an antigen-specific immunotherapy for young people with type 1 ...
Follicle-stimulating hormone receptor (FSHR) N680S–genotyped women treated with either recombinant FSH or urinary FSH had higher pregnancy rates of 51% vs 40% in non-genotyped control individuals.